Proceedings of 33rd Annual General Meeting of Orchid Pharma Limited Held on 29th September 2026

OrchidPharm~W -- A Dhanuka Group Company ---------------------------------------- September 29, 2026 National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulations, 2015, as amended Sub: Proceedings of the 33rd Annual General Meeting ("AGM") of Orchid Pharma Limited ("the Company") held on September 29, 2026 Dear Sir/Madam, With reference to the captioned subject and in accordance with Regulation 30 read with Schedule III, Para A Part A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, please find enclosed herewith Summary Proceedings of 33rd Annual General Meeting of the Company held on September 29, 2026, commenced at 12:00 Noon (1ST) and concluded at 12:43 P.M. (IST). The same is also available on the official website of the Company at https:l/www.orchidpharma.com/investors. Kindly take the above on your records. Thanking you, For Orchid Pharma Limited Kapil Dayya Company Secretary and Compliance Officer Mem. No. Fl0698 Encl.: as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1. DL~ Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. OrchidPharm~W -- A Dhanuka Group Company -------------------------------------___ Summary Proceedings of the 33rd Annual General Meeting of Orchid Pharma Limited held today i.e. Tuesday, September 29, 2026 at 12:00 Noon (1ST) through Video Conference ("VC"l! Other Audio-Visual Means ("OAVM") PRESENT THROUGH VIDEO CONFERENCING Location Mr. Manish Dhanuka Managing Director Gurugram Mr. Arjun Dhanuka Whole Time Director Guruqram CA (Dr.) Manoj Kumar Goyal Independent Director and Chairman of the Audit Noida Committee and nominated member of Stakeholders Relationship Committee and Nomination and Remuneration Committee Ms. Shubha Singh Independent Woman Director Noida Ms. Tanu Singla Independent Woman Director New Delhi IN ATTENDANCE Mr. Kapil Dayya Company Secretary & Compliance Officer Gurugram INVITEES Mr. Sunil Kumar Gupta Chief Financial Officer Mr. Nishant Dalal Vice-President Finance Mr. Sudesh Choraria Authorized Representative of Mis. Sing hi & Co., Statutory Auditor Mr. N. Ramanathan Authorized Representative of Mis. S. Dhanapal & Associates LLP Secretarial Auditor Mr. Muthukumaran Partner, Practising Company Secretary, Mis. Muthukuman & Associates, Scrutinizer The 33rd Annual General Meeting ("AGM") of the Members of Orchid Pharma Limited ("the Company") held on Tuesday, September 29, 2026 at 12:00 Noon erST) through Video Conferencing ("VC")I Other AudiO Visual Means ("OAVM") at the deemed venue; Registered Office of the Company. Members present through VC/OAVM: 32 Mr. Kapil Dayya, Company Secretary welcomed the members and briefed certain procedural and technical information regarding the participation and voting by the Members through VCIOAVM at the meeting. Mr. Manish Dhanuka, Managing Director of the Company welcomed the members and introduced the Board of Directors and attendees, who attended the meeting through Video Conferencing. He further informed the members that Mr. Ram Gopal Agarwal, Non-Executive Director cum Chairman of the Board of Directors, Mr. Mridul Dhanuka, Whole-Time Director and Dr. Dharam Vir, Independent Director, had sought leave of absence from the meeting. The Managing Director also recorded the attendance of Mr. Sunil Kumar Gupta, Chief Financial Officer, Mr. Nishant Dalal, Vice-President Finance, Mis. Singhi & Co., Statutory Auditors, Mis. S Dhanapal & Associates LLP, Secretarial Auditors of the Company and Mis. P Muthukumaran & Associates, Scrutinizer at the AGM. Thereafter, given the absence of Mr. Ram Gopal Agarwal from the meeting and pursuant to Articles of Association of the Company read with Secretarial Standard- 2 issued by the Institute of Company Secretaries of India, Mr. Manish Dhanuka was appointed as the Chairman of the AGM. The Chairman confirmed the presence of requisite quorum and called the meeting to order. +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. OrchidPharm~W -- A Dhanuka Group Company The Notice of AGM dated September 07, 2026 was taken as read and the Chairman delivered his speech highlighting Company's journey throughout the Financial Year 2025-26 with some financial insights ?lnd the macro-economic outlook. The Company Secretary on the instructions of the Chairman informed the members that the Auditors' Report on Standalone Financial Statements of the Company for the Financial Year ended March 31, 2026 does not contain any qualification. However, there are certain qualifications made by Statutory Auditors in the Consolidated Auditor's Report, which along with the management's response were included in the statement on Impact of Audit Qualifications (for Audit reports with modified opinion) which forms part of Annual Report. The Members were also informed about the comments/remarks of the Secretarial Auditors of the Company in their Report issued for the Financial Year 2025-26 along with the Management response included in the Board's Report for the same Financial Year. Thereafter, the Company Secretary with the permission of chairman read out the businesses, as set out in the Notice convening the 33rd Annual General Meeting, for Members' consideration and approval: S. Resolution Type of No. Resolution 1. Adoption of the Revised financial statements, including the Consolidated Ordinary financial statements for the financial year ending March 31, 2026, including Resolution the report of the Board of Directors and auditors thereon. 2. Appointment of Mr. Mridul Dhanuka (DIN: 00199441) Whole-Time Director Ordinary of the Company, who retires by rotation and being eligible, offers himself Resolution for reappointment. 3. Ratification of remuneration of the Cost Auditor of the Company for the Ordinary Financial Year 2026-27. Resolution 4. *Approval for Material Related Party Transactions with M/s. Otsuka Ordinary Chemical (India) Private Limited. Resolution 5. Appointment of Mr. Arjun Dhanuka (DIN:00454689) as Whole-time Director Special of the Company and payment of remuneration to him (earlier deSignated as Resolution Non-Executive, Non-Independent Director) *Since Mr. Manish Dhanuka was interested in the agenda item, he stepped down as Chairman and nominated CA (Dr.) Manoj Kumar Goyal, Independent Director to Chair the AGM to transact the business i.e. Item NO.4. Post transacting the said business, Mr. Manish Dhanuka resumed the Chair and proceeded with the AGM. Thereafter, the Company Secretary explained the e-voting procedure to members in detail and requested to exercise their right to cast vote through e-voting at the AGM, in case they have not, during the remote e-voting period. The members who had registered themselves as speaker shareholders were invited to express their views and queries raised by them were suitably replied and requests raised/ suggestions given, were taken on report by the Management. Further, the Company Secretary informed the Members to send their questions/clarifications, if any, to email [Showing first 8,000 characters — download PDF for full document]